J. Tonkinson

发表

FAST slides: a novel surface for microarrays.

B. Stillman, J. Tonkinson, B. A. Stillman, 2000, BioTechniques.

Expression microarray hybridization kinetics depend on length of the immobilized DNA but are independent of immobilization substrate.

B. Stillman, J. Tonkinson, Brett A. Stillman, 2001, Analytical biochemistry.

Phosphorothioate oligodeoxynucleotides--anti-sense inhibitors of gene expression?

J. Tonkinson, L. Yakubov, C. Stein, 1991, Pharmacology & therapeutics.

Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cells.

S. Rotenberg, J. Tonkinson, J. Gervasoni, 1993, Biochemistry.

Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy.

Qiuyan Zhao, A. Krieg, S. Matson, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Patterns of intracellular compartmentalization, trafficking and acidification of 5'-fluorescein labeled phosphodiester and phosphorothioate oligodeoxynucleotides in HL60 cells.

C. Stein, J. Tonkinson, 1994, Nucleic acids research.

Induction of phosphorylation on BRCA1 during the cell cycle and after DNA damage.

P. Polakis, J. Tonkinson, B. Rubinfeld, 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Stimulation of calcium influx in HL60 cells by cholesteryl-modified homopolymer oligodeoxynucleotides.

I. Schieren, J. Tonkinson, C. Stein, 1992, Antisense research and development.

Cell surface binding and cellular internalization properties of suramin, a novel antineoplastic agent.

J. Tonkinson, C. Stein, T. Khan, 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

Cell cycle modulation by a multitargeted antifolate, LY231514, increases the cytotoxicity and antitumor activity of gemcitabine in HT29 colon carcinoma.

J. Tonkinson, J. Worzalla, C. Teng, 1999, Cancer research.

Preclinical cellular pharmacology of LY231514 (MTA): a comparison with methotrexate, LY309887 and raltitrexed for their effects on intracellular folate and nucleoside triphosphate pools in CCRF-CEM cells.

R. Schultz, C. Shih, J. Tonkinson, 1998, British Journal of Cancer.

Cellular pharmacology and protein binding of phosphoromonothioate and phosphorodithioate oligodeoxynucleotides: a comparative study.

M. Caruthers, J. Tonkinson, L. Yakubov, 1994, Antisense research and development.

Antisense Nucleic Acids — Prospects for Antiviral Intervention

C. Stein, J. Tonkinson, 1993 .

Determination of cellular internalization of fluoresceinated oligonucleotides.

C. Stein, L. Benimetskaya, J. Tonkinson, 2000, Methods in enzymology.

Mechanistic Aspects of the Interaction of Polyanionic Oligodeoxynucleotides with HL60 Cells

S. Rotenberg, J. Tonkinson, J. Gervasoni, 1992, Annals of the New York Academy of Sciences.

Nitrocellulose: a tried and true polymer finds utility as a post-genomic substrate.

B. Stillman, J. Tonkinson, B. A. Stillman, 2002, Frontiers in bioscience : a journal and virtual library.

The antiproliferative and cell cycle effects of 5,6,7, 8-tetrahydro-N5,N10-carbonylfolic acid, an inhibitor of methylenetetrahydrofolate dehydrogenase, are potentiated by hypoxanthine.

S. B. Gates, L. L. Habeck, J. Tonkinson, 1998, The Journal of pharmacology and experimental therapeutics.

Cell cycle effects of antifolate antimetabolites: implications for cytotoxicity and cytostasis

R. Schultz, C. Shih, J. Tonkinson, 1997, Cancer Chemotherapy and Pharmacology.

Antisense oligodeoxynucleotides as clinical therapeutic agents.

C. Stein, J. Tonkinson, 1996, Cancer investigation.

Binding of phosphorothioate oligodeoxynucleotides to basic fibroblast growth factor, recombinant soluble CD4, laminin and fibronectin is P-chirality independent.

W. Stec, L. Benimetskaya, B. Karwowski, 1995, Nucleic acids research.

Phosphorothioate Oligodeoxynucleotides Bind to Basic Fibroblast Growth Factor, Inhibit Its Binding to Cell Surface Receptors, and Remove It from Low Affinity Binding Sites on Extracellular Matrix (*)

C. Stein, J. Tonkinson, I. Vlodavsky, 1995, The Journal of Biological Chemistry.

A BRCA1 mutant alters G2-M cell cycle control in human mammary epithelial cells.

M. Lai, J. Tonkinson, J. Larson, 1997, Cancer research.

An assessment of the antithymine and antipurine characteristics of MTA (LY231514) in CCRF-CEM cells.

R. Schultz, C. Shih, J. Tonkinson, 2000, Advances in enzyme regulation.

Automated analysis of tissue microarrays.

D. Rimm, M. Dolled-Filhart, R. Camp, 2010, Methods in molecular biology.

Cellular pharmacology of MTA: a correlation of MTA-induced cellular toxicity and in vitro enzyme inhibition with its effect on intracellular folate and nucleoside triphosphate pools in CCRF-CEM cells.

R. Schultz, C. Shih, J. Tonkinson, 1999, Seminars in oncology.